Kinnevik AB (publ)
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 13, 2025), Kinnevik AB (publ) reported 1 stock position worth $68.0 million. Its top holding was Recursion Pharmaceuticals-A (RXRX) at 100.0% of the portfolio. Its holdings were unchanged from Q1 2025.
- Most Recent 13F
- Q3 2025
- Location
- STOCKHOLM, V7
- CIK
- 0001766574
- Portfolio Value
- $68.0M (Q2 2025)
- SEC Filing
- 0001415889-25-021634 ↗ filed Aug 13, 2025
Holdings Value
Holdings 1 stocks · $68.0M
| RXRX Recursion Pharmaceuticals-A | 100.00% | 13,434,171 | $68.0M | No change |
Portfolio Sells Q1 2025 → Q2 2025
| None this quarter. | |||
Portfolio Buys Q1 2025 → Q2 2025
| None this quarter. | |||